INTERACTION BETWEEN FK506 AND CLOTRIMAZOLE IN A LIVER TRANSPLANT RECIPIENT
- 1 December 1991
- journal article
- case report
- Published by Wolters Kluwer Health in Transplantation
- Vol. 52 (6) , 1086-7
- https://doi.org/10.1097/00007890-199112000-00029
Abstract
An abstract is unavailable. This article is available as a PDF only.This publication has 9 references indexed in Scilit:
- Measurement of FK 506 by HPLC and isolation and characterization of its metabolites.1991
- Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.1991
- Liver, Kidney, and Thoracic Organ Transplantation Under FK 506Annals of Surgery, 1990
- Assay of FK 506 in plasma.1990
- FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATIONThe Lancet, 1989
- Cyclosporin‐erythromycin interaction in renal transplant patients.British Journal of Clinical Pharmacology, 1989
- Clinical Pharmacokinetics in Organ Transplant PatientsClinical Pharmacokinetics, 1989
- Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.Journal of Clinical Investigation, 1987
- Clinical Pharmacokinetics of CyclosporinClinical Pharmacokinetics, 1986